Verinata Health
Facebook  YouTube  Twitter 
  • Company
    • Overview   |
    •    Management   |
    •    Advisory Boards   |
    •    Our Lab   |
    •    Careers
  • Providers
    • verifi® test   |   
    • New Approach   |   
    • verifi® Advantage   |   
    • Test Results   |   
    • Support   |   
    • Clinical Data   |   
    • Sample Logistics   |   
    • FAQs  |  
    • Guidelines & Policies
  • Patients
    • Overview   |
    •   FAQs  |
    •   Billing FAQs
  • Payers
    • Overview   |
    •    Product Overview   |
    •    Clinical Utility   |
    •    Economic Validity   |
    •    Additional References
  • News
    • Featured News   |
    •    Events   |
    •    In the News   |
    •    Publications   |   
    • Webcasts
Verinata is developing simple, non-
invasive alternatives to the invasive testing
methods available today.

Dr. Diana Bianchi Presents Data Demonstrating Verinata’s Proprietary Technology Detects Genetic Abnormalities in Twin Pregnancies

National guidelines recommend that all pregnant women should be offered prenatal screening for fetal abnormalities with an emphasis on early, non-invasive testing options.

1 Data on file. Verinata Health, Inc.

© Verinata Health 2011 - 2013
Site Map
|
Contact Us
|
Privacy Policy
|
Position Statement
|
Terms of Use